VERONICA SALAICES-FRAIRE: Open Payments
NPI 1215428511 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 52 payments from 14 companies in 2025. Trend: 2023 $519 · 2024 $868 · 2025 $985
Food & beverage: $985
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $277 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $151 |
| Novo Nordisk Inc | 6 | $109 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Corcept Therapeutics | 2 | $78 |
| Lilly USA, LLC | 4 | $77 |
| Organon LLC | 2 | $39 |
| Cipher Pharmaceuticals US LLC | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Amgen Inc. | 1 | $19 |
Products named: Kerendia, XIFAXAN, JARDIANCE, Korlym, Ozempic, NEXPLANON, Natroba, BREZTRI.
Industry payments across TX — which companies pay providers there.
